GLP-1 news

Early Generic Semaglutide in Canada

Public Comment Closes on the FDA Plan to Permanently Bar Bulk Compounding of Semaglutide and Tirzepatide

Slim Shady: Smugglers Eye Big Profits Running Weight Loss Drugs into Brazil

UPS, FedEx and logistics giants are investing in the healthcare boom

Axios Live: Safety concerns fuel push for compounded GLP-1 oversight

LifeMD, a popular telehealth firm, put profits over patient safety, ex-workers say

How to avoid fake weight-loss injections in Costa Rica

GLP-1 Fraud: Asheville wellness owner charged with distributing unlicensed tirzepatide

GLP-1 overdose sends North Carolina woman to hospital

Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders | Psychiatry and Behavioral Health | JAMA Psychiatry | JAMA Network

Doctor and pharmacist accused of unsafe GLP-1 compounding

Online Prescribing of GLP-1 Receptor Agonists | Diabetes | JAMA | JAMA Network

In U.S., GLP-1 Usage Reaches New High

UK unable to tackle weight-loss drug black market, MP warns | The Independent

Dutch hospitals issue warning after fake weight-loss drugs cause comas | NL Times

GLP-1 weight loss boom made Empower Pharmacy a national powerhouse

‘Grave allegations’: Gurgaon court denies bail to fake Mounjaro racket mastermind | Delhi News - The Indian Express

Are People With Eating Disorders Misusing GLP-1 Drugs? | MedPage Today

GLP-1 reimbursement crisis: What independent pharmacies need to know about staying viable | Pharmacy Times

Record retatrutide haul found in illegal pharmacy laboratory | eKathimerini.com

Warning on promoting newly licensed prescription-only medicines and unlicensed medicines for weight management - GOV.UK

FDA steps up crackdown on compounded GLP-1s - EMJ GOLD

Alarming rise in weight loss drug overdoses

Are GLP-1 compounds safe? Not from this company and supplier, whistleblowers say – NBC Bay Area

The warning doctors want every Ozempic, Wegovy and Mounjaro user to hear about fake versions

TGA seizes millions of illegal and counterfeit goods as part of global crackdown

Another Ohio beauty spa loses license over bootleg drug allegations

Generic semaglutide race hinges on API supply as China leads: Goldman Sachs - The HinduBusinessLine

Eli Lilly wins argument over Noom’s GLP-1 dosing claims

She lost 110 pounds on a $199 weight loss drug. Knowing the risks, she's still taking it. | king5.com